IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME (IRIS) INCIDENCE IN PATIENTS STARTING ANTIRETROVIRAL THERAPY (ART) EARTLIER VERSUS LATER DURING TUBERCULOSIS (TB) THERAPY- A SYSTEMIC REVIEW AND META-ANALYSIS OF COHORT SUTDIES
Author(s)
Tan X1, Chang J2, Patel I1, Balkrishnan R11The University of Michigan, Ann Arbor, MI, USA, 2The Pennsylvania State University, Hershey, PA, USA
OBJECTIVES: The optimal timing of initiation of Antiretroviral Therapy (ART) in ART naïve patients with HIV and TB co-infection remains inconclusive. IRIS incidence is one of the most important outcomes that we need to consider when making a decision on the time of initiating ART. This study compared the IRIS incidence in patients initiating ART earlier (
Conference/Value in Health Info
2012-09, ISPOR Asia Pacific 2012, Taipei, Taiwan
Value in Health, Vol. 15, No. 7 (November 2012)
Code
PIN5
Topic
Clinical Outcomes
Topic Subcategory
Comparative Effectiveness or Efficacy
Disease
Infectious Disease (non-vaccine), Multiple Diseases